Evidence-Based Medicine Guidelines
Infliximab for rheumatoid arthritis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Infliximab for Rheumatoid Arthritis." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453726/0/__________Infliximab_for_rheumatoid_arthritis______.
Infliximab for rheumatoid arthritis. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/453726/0/__________Infliximab_for_rheumatoid_arthritis______. Accessed November 4, 2025.
Infliximab for rheumatoid arthritis. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/453726/0/__________Infliximab_for_rheumatoid_arthritis______
Infliximab for Rheumatoid Arthritis [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 November 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453726/0/__________Infliximab_for_rheumatoid_arthritis______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Infliximab for rheumatoid arthritis
ID - 453726
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453726/0/__________Infliximab_for_rheumatoid_arthritis______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
